![Gennaro de Libero](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Gennaro de Libero is the founder of Matterhorn Biosciences AG, where he currently holds the title of Co-Chief Scientific Officer.
The company was founded in 2020.
Actieve functies van Gennaro de Libero
Bedrijven | Functie | Begin |
---|---|---|
Matterhorn Biosciences AG
![]() Matterhorn Biosciences AG BiotechnologyHealth Technology Matterhorn Biosciences AG operates as a holding company, which provides biotechnology solutions. It specializes in the development of T cell receptor therapies that are based on MR1T cells, and that recognize and kill tumors of tissue origins. The company was founded by Gennaro De Libero and Lucia Mori on August 5, 2020 and is headquartered in Basel, Switzerland. | Oprichter | 05-08-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Matterhorn Biosciences AG
![]() Matterhorn Biosciences AG BiotechnologyHealth Technology Matterhorn Biosciences AG operates as a holding company, which provides biotechnology solutions. It specializes in the development of T cell receptor therapies that are based on MR1T cells, and that recognize and kill tumors of tissue origins. The company was founded by Gennaro De Libero and Lucia Mori on August 5, 2020 and is headquartered in Basel, Switzerland. | Health Technology |